Proc Natl Acad Sci U S ACold Spring Harb Symp Quant Biolencorafenibdabrafenibpancreatic adenocarcinomaNRAS mutant melanomaBRAF inhibitorsNRAS-mutant melanomaPDACimmunotherapy+2 more
…ooperating mutations and pathways in pancreatic adenocarcinoma. Proc Natl Acad Sci U S A. 2012;109,5934–5941.Abstract 878 Figure 1Paradoxical activation…